Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Sotevtamab |
| Trade Name | |
| Synonyms | AB 16B5|AB16B5|AB-16B5 |
| Drug Descriptions |
Sotevtamab is a monoclonal antibody that inhibits the activity of tumor associated human clusterin (sCLU), potentially decreasing epithelial-to-mesenchymal transition and reducing tumor growth (J Clin Oncol 42, 2024 (suppl 16; abstr 8577)). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C121778 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Docetaxel + Sotevtamab | Docetaxel Sotevtamab | 0 | 1 |
| Fluorouracil + Leucovorin + Oxaliplatin + Sotevtamab | Fluorouracil Leucovorin Oxaliplatin Sotevtamab | 0 | 1 |
| Sotevtamab | Sotevtamab | 0 | 1 |